Your browser doesn't support javascript.
loading
Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes.
Winer, S; Gunaratnam, L; Astsatourov, I; Cheung, R K; Kubiak, V; Karges, W; Hammond-McKibben, D; Gaedigk, R; Graziano, D; Trucco, M; Becker, D J; Dosch, H M.
Affiliation
  • Winer S; Department of Immunology, University of Toronto, Ontario, Canada.
J Immunol ; 165(7): 4086-94, 2000 Oct 01.
Article in En | MEDLINE | ID: mdl-11034420
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Prediabetic State / Autoantigens / Histocompatibility Antigens Class II / Diabetes Mellitus, Type 1 Limits: Animals Language: En Journal: J Immunol Year: 2000 Document type: Article Affiliation country: Canada Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Prediabetic State / Autoantigens / Histocompatibility Antigens Class II / Diabetes Mellitus, Type 1 Limits: Animals Language: En Journal: J Immunol Year: 2000 Document type: Article Affiliation country: Canada Country of publication: United States